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Abstract A novel human guanylate-binding protein (GBP)
hGBP3 was identi¢ed and characterized. Similar as the two
human guanylate-binding proteins hGBP1 and hGBP2,
hGBP3 has the ¢rst two motifs of the three classical guany-
late-binding motifs, GXXXXGKS (T) and DXXG, but lacks the
N (T) KXD motif. Escherichia coli-expressed hGBP3 protein
speci¢cally binds to guanosine triphosphate (GTP). Using a
yeast two-hybrid system, it was revealed that the N-terminal
region of hGBP3 binds to the C-terminal regulatory domain
of NIK/HGK, a member of the group I GCK (germinal center
kinase) family. This interaction was con¢rmed by in vitro glu-
tathione-S-transferase (GST) pull-down and co-immunoprecipi-
tation assays.
1 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Guanine nucleotide-binding proteins play important roles
in various basic cellular processes such as protein synthesis,
signal transduction, intracellular protein transportation, cell
proliferation and di¡erentiation, and regulation of cytoskele-
ton [1,2]. Most known guanine nucleotide-binding proteins
contain three classical motifs : GXXXXGK (S/T), DXXG
and (N/T) KXD [3,4]. If present in a given protein sequence
in an ordered fashion and with typical spacing, these motifs
are highly indicative for associated guanine nucleotide-binding
activity [3]. Structural analysis of P21-ras [5], elongation fac-
tor Tu [6^8] and human guanylate-binding protein 1 (hGBP1)
[9] indicated that these motifs formed a part of the guanosine
triphosphate (GTP)-binding pocket. Some guanine nucleotide-
binding proteins including p21 ras [10^12] and heterotrimeric
G proteins [13] harbor at their C-terminal an additional
CAAX motif, which functions as an isoprenylation signal
and thus ensures the proper anchoring of these proteins in a
membrane [14,15].
Among the guanine-binding proteins, a group of proteins,
named GTP-binding proteins (GBPs), are interferon-inducible
and can be immobilized by agarose-guanylate nucleotide
[16,17]. A characteristic feature of those GBPs is that they
lack the third classical motif (N/T) KXD, and might also
lack the C-terminal motif CAAX [3]. Thus far GBPs have
been identi¢ed in human [14,18^21], mouse [20,21], rat [21]
and chicken [23], as well as in Drosophila and Caenorhabditis
elegans [24]. However, the physiological roles of these GBPs
remain elusive. GBPs can be accumulated to high level in the
interferon-treated cells and thus qualify as potential intracel-
lular mediators of the interferon-induced antiviral and anti-
proliferation e¡ect. Overexpression of hGBP1 or hGBP2
blocks the replication of nesiculul stomatitis virus and ence-
phalomyocarditis virus in HeLa cells [25]. However, GBP1
knock-out mice and cells derived from such mice are not
more susceptible to viral infections than their wild counter-
parts [24].
Human Nck-interacting kinase/HPK/GCK-like kinase
(NIK/HGK) [4] is a member of the group I germinal center
kinases (GCKs), a group of mitogen-activated protein kinase
kinase kinase kinases (MAP4K) that activate the SAPK/JNK
cascade in a variety of cell types [4,22,26^29]. At least ¢ve
members of this group have been identi¢ed including GCK
[30], GCK-related kinase (GCKR) [27], GCK-like kinase
(GLK) [26], hematopoietic progenitor kinase 1 (HPK1) [22]
and NIK/HGK [4]. Like other members of the group I
GCKs, NIK/HKG is composed of an N-terminal kinase do-
main and a highly conserved C-terminal regulatory domain
necessary for its kinase activity [4]. The C-terminal domain
consists of a hydrophobic leucine-rich CHN domain, a 140^
150 amino acid stretch, a C-terminal (CT) region [4], in addi-
tion to at least two proline/glutamic acid/serine/threonine
(PEST) motifs and two polyproline consensus-binding sites
for proteins containing Src homolog (SH-3) domains [4]. Hu-
man NIK/HGK was originally identi¢ed based on its inter-
action with Nck and homology to HPK and GCK [28,29]. It
could activate JNK through TAK and/or MEKK1CMKK4
and MKK7CJNK kinase cascade [28,29].
As a part of our e¡ort to search for brain-speci¢c genes
involved in signal transduction, we cloned a novel GBP ho-
molog, hGBP3, and identi¢ed the CHN domain of NIK/
HGK as its binding partner.
2. Materials and methods
2.1. Cloning of hGBP3 and database search
The 5P rapid ampli¢cation of cDNA ends (5P-RACE) was per-
formed using human brain Marathon cDNA library (Clontech) with
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a gene-speci¢c primer 5P-TCA ACA TGA AGT CCA TC-3P following
the manufacturer’s protocol. The polymerase chain reaction (PCR)
product obtained was gel puri¢ed, and cloned into pcDNA3.1 (3)/
Myc-His A vector (Novagen) and subsequently sequenced.
2.2. GTP-binding assay
The coding sequence of the hGBP3 gene was generated by PCR
from a human Marathon cDNA library (Clontech) using the primers
5P-GGC GGT CGA CAT GGC CAA GAA CCT CAG G-3P and 5P-
GGC GCT CGA GCA TTT TTT TCT TTT CTG ATT GTT C-3P.
The PCR product was cloned into the PET22b (+) (Novagen) between
the SalI and XhoI recognition sites. The resulted plasmid encoded
hGBP3 protein tagged by (His)6 at the C-terminal. The (His)6-tagged
hGBP3 protein was induced by 0.1 mM isopropyl beta-D-thiogalacto-
side (IPTG) in Escherichia coli BL21(DE3) at 30‡C for 3 h and puri-
¢ed using TALon-Nx Metal Resin Column (Clontech) according to
the manufacturer’s protocol. Binding assays were carried out using
5 Wg puri¢ed recombinant hGBP3 and GTP- and CTP-agarose
(Sigma) as described [32]. Bound proteins were eluted and analyzed
on sodium dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^
PAGE), and visualized by Coomassie blue staining. For the competi-
tion experiment, the reaction system was suspending 10 mM of com-
petitor before adding the puri¢ed hGBP3.
2.3. Northern blot analysis
Northern blot analysis was carried out using Human 12-Lane MTN
Blot membrane (Clontech) as per manufacturer’s protocol. The
hGBP3 probe derived from its 3P untranslated region (base 1840^
2300) was prepared by random primer labeling with [K32P]dATP using
a prime-a-gene labeling system kit (Promega). After prehybridization,
hybridization and highly stringent washing, the membrane was ex-
posed to an X-ray ¢lm (Eastman Kodak Co.) for 48 h at 380‡C.
2.4. Yeast two-hybrid screening and mapping of hGBP3 for the region
binding to NIK/HGK
The complete coding region of hGBP3 was inserted into pLexA
(Clontech) and used as bait to screen a human adult brain cDNA
library in pB42AD vector in a yeast strain EGY48 possessing the
p8op-Laz reporter plasmid (Clontech). Approximately 2U106 yeast
transformants were screened according to the manufacturer’s instruc-
tion. For mapping the region of hGBP3 that mediated the interaction
between hGBP3 and NIK/HGK, N- or C-terminal truncated hGBP3
mutants were fused with LexA protein in vector pLexA and the CHN
domain of HGK was fused with B42 transactivation domain in vector
pB42AD.
2.5. Glutathione-S-transferase (GST) pull-down and
co-immunoprecipitation assays
A DNA fragment encoding the C-terminal 367 amino acids of
NIK/HGK was inserted into pGEX-2T (Amersham Pharmacia Bio-
tech). The resulting plasmid GST367 encoding a recombinant protein
was transformed into E. coli BL21(DE3). GST367 was induced by
using 0.1 mM IPTG at 30‡C for 3 h and puri¢ed using glutathione-
Sepharose 4B beads (Amersham Pharmacia Biotech). 50 Wl hGBP3-
(His)6, 50 Wl GST367 and 100 Wl bu¡er 1 (50 mM Tris^Cl pH 8.0, 150
mM NaCl, 0.1% Nonidet P-40, 50 Wg/ml soybean trypsin inhibitor,
100 Wg/ml leupeptin and 40 Wg/ml phenylmethylsulfonyl £uoride) were
mixed and incubated for 1 h at room temperature with end-on-end
shaking. The beads were separated by a brief centrifugation, washed
¢ve times with bu¡er 1, and suspended in 25 Wl SDS sample loading
bu¡er (50 mM Tris^Cl pH 6.8, 100 mM DTT, 2% bromophenol blue,
10% glycerol). The bound protein was analyzed by Western blot using
anti-His antibody (NeoMmarkers).
For co-immunoprecipitation, hGBP3 was cloned into pcDNA3.1
(3)/Myc-His A and tagged at the C-terminal with a Myc epitope,
and the C-terminal 367 amino acids of NIK/HGK (HGK367) were
inserted into pcDNA3.0 and tagged at the C-terminal with a FLAG
epitope (DYKDDDDK). Meanwhile, as controls Aequorea victoria
green £uorescent protein (GFP) and NIK/HGK without the last
367 amino acids (HGKv367) were also inserted into pcDNA3 and
tagged with a FLAG epitope at the C-terminals. The plasmids were
transfected into 293T cells cultured in Dulbecco’s modi¢ed Eagle’s
medium (DMEM) containing 10% fetal bovine serum (FBS) using
the lipofectamine plus reagent (Gibco) following the manufacturer’s
instruction. The cells were harvested 48 h after transfection and lysed
using M-PER mammalian protein extraction reagent (Pierce) at room
temperature for 10 min. Nuclear and cellular debris was removed by
centrifugation at 10 000Ug for 15 min at 4‡C. Cell extracts were in-
cubated with 2 Wg/ml of mouse anti-myc antibody (Calbiochem) over-
night at 4‡C. Protein A-agarose beads (Amersham Pharmacia Bio-
tech) were then added and incubated for 2 h at room temperature.
The immunoprecipitated samples were washed extensively with phos-
phate-bu¡ered saline (PBS) and then boiled in SDS loading bu¡er.
The supernatant was subjected to 12% SDS^PAGE and protein was
transferred to nitrocellulose membrane (Schleincher and Schucell).
The membrane was immunoblotted with chicken anti-FLAG antibody
and horseradish peroxidase-conjugated goat anti-chicken IgY (Aves
labs). The signals were detected using the ECL system (Amersham
Pharmacia Biotech).
3. Results
3.1. Brain-speci¢c hGBP3 has a GTP-binding activity
An EST contig encoding a partial protein homolog to
hGBP1 and hGBP2 was identi¢ed by searching brain-speci¢c
ESTs in a human-expressed sequence tag (EST) database
(www.ncbi.nlm.nih.gov/). The complete mRNA sequence ob-
tained by 5P-RACE and reverse transcriptase (RT)-PCR was
based on the EST sequences. The novel mRNA consisted of a
1675-bp open reading frame (ORF) with the ATG translation
initiation code in a Kozak consensus sequence [31], and a
putative polyadenylation signal AATAAA in the 3P untrans-
lated region (GenBank accession number AF444143). The
putative protein deduced from the ORF is approximately 63
kDa in molecular mass, contained two of the three guanylate-
binding classical motifs: GXXXXGK (S/T) and DXXG, and
lacked the third motif (N/T) KXD (Fig. 1), suggesting a struc-
tural homology to hGBP1 and hGBP2. It was designated
hGBP3.
HGBP3 is conserved during the evolution. Both Drosophila
melanogaster and C. elegans have hGBP3 homologs. HGBP3
displays 49.0 and 51.6% amino acid identities to the homologs
from C. elegans (GenBank accession number AAK68527) and
D. melanogaster (GenBank accession number AAF56318), re-
spectively.
It was previously suggested that the GXXXXGKS (T) and
DXXG motifs are highly indicative for associated guanine
nucleotide-binding activity [3]. Since the hGBP3 contained
the motifs, E. coli-expressed hGBP3 was incubated with aga-
rose-GTP beads to test its GTP-binding capacity. As ex-
pected, agarose-GTP was able to recover hGBP3 protein
while agarose-CTP failed to do so (Fig. 2A). Competition
experiment showed that the binding of hGBP3 to agarose-
GTP could be signi¢cantly reduced by free GTP but not af-
fected by ATP and CTP (Fig. 2A), indicating the binding of
hGBP3 to GTP was speci¢c.
The expression pattern of hGBP3 was investigated in a
variety of human tissues by Northern hybridization. Two
transcripts approximately 2.4 and 2.0 kb in length in brain
C
Fig. 1. Sequence analysis of hGBP3. The nucleotide sequence and the deduced amino acid sequence. The Kozak consensus and polyadenylation
signal AATAAA are underlined by dashed lines; the GXXXXKS (T) and DXXG motifs are underlined by solid lines. The hGBP3P GenBank
accession number is AF444143.
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and a 2.0-kb transcript in placenta were observed, but not in
other tissues examined (Fig. 2B), suggested that the hGBP3
expression was brain-speci¢c in adult, consistent to the result
from searching the EST database.
3.2. The N-terminal region of hGBP3 speci¢cally binds to the
CHN domain of the HIK/HG
Biological function of hGBP3 was investigated by screening
a human adult brain cDNA library using a yeast two-hybrid
assay in order to identify proteins binding to hGBP3 protein.
Approximately 2U106 yeast transformants were screened.
One clone capable of growing in selective media and display-
ing a strong galactosidase signal was identi¢ed. Sequence
analysis indicated that the clone encoded a partial regulatory
domain (a complete CHN domain) of the NIK/HGK protein,
a member of the group I GCK kinases which could activate
JNK kinase in 293T cells. The C-terminal regulatory domain
of NIK/HGK is necessary for its N-terminal kinase activity.
In order to con¢rm the interaction of hGBP3 and NIK/
HGK, a fusion protein (GST367) containing the regulatory
domain (the C-terminal 367 residuals) of NIK/HGK fused to
a bacterial GST was employed to pull-down the E. coli-ex-
pressed hGBP3 in vitro. GST protein was used as a control to
test the speci¢city of the binding. The Western blot results
showed that the hGBP3 protein bound to the GST367 fusion
protein whereas no interaction between hGBP3 and GST was
detected (Fig. 3A), con¢rming the speci¢city of the GST367^
hGBP3 interaction.
HGBP3-myc was subsequently used to co-immunoprecipi-
tate the FLAG-tagged CHN domain of NIK/HGK by tran-
sient transfection of pcDNA3.1-hGBP3-myc and pcDNA3-
NIK/HGK-FLAG plasmids in 293T cells, using anti-myc
antibody and protein A-agarose. Truncated NIK/HGK pro-
tein lacking the CHN domain was not precipitated by hGBP3,
consistent with the in vitro GST pull-down experiment (Fig.
3B).
To further map the region binding to NIK/HGK, the
C- and N-terminal truncated hGBP3 were tested for their
interaction with the CHN domain of NIK/HGK in the yeast
two-hybrid system (Fig. 4). The N-terminal 129 amino acid
Fig. 2. The GTP-binding property and expression of hGBP3 in hu-
man tissues. A: GTP-binding assay. 5 Wg puri¢ed recombinant
hGBP, (his)6 tagged at the C-terminal was mixed with 30 Wl aga-
rose-GTP beads (lane 1), or 30 Wl agarose-CTP beads (lane 2). The
bound material was analyzed by 10% SDS^PAGE and stained with
Coomassie blue. For the competition experiment, the reacting sys-
tem was suspended with 10 mM GTP (lane 5), CTP (lane 3), and
ATP (lane 4). Lane 6, puri¢ed hGBP3 protein. B: Northern blot
analysis of hGBP3 mRNA in human tissues. 1 Wg of polyAþ RNA
from human tissue was run on each lane. The same was hybridized
with L-actin probe (bottom panel). The molecular size was marked
on the right side of the panel.
Fig. 3. Con¢rmation of hGBP3^NIK/HGK interaction. A: GST
pull-down assay of hGBP3 and NIK/HGK. Proteins bound to the
GST fusion proteins were eluted and analyzed by Western blot us-
ing an anti-His antibody. Bacterially expressed hGBP-His (lane 1)
was mixed with bacterially expressed GST fused to the C-terminal
of NJK/HGK (lane 2) or GST (lane 4), and incubated with gluta-
thione-Sepharose 4B beads. lanes 2 and 5, wash bu¡er from ¢fth
washing. B: Co-immunoprecipitation of hGBP3 and NIK/HGK.
Plasmid encoding hGBP3-myc was co-transfected into 293T cells
with the plasmid encoding the CHN domain of NIK/HGK-FLAG
(HGK367) (lane 2), the plasmid encoding NIK/HGK deleting the
CHN domain also tagged with FLAG (HGKv376) (lane 3), or the
plasmid encoding GFP-FLAG (lane 4). 48 h after transfection, the
cells were lysed and co-immunoprecipitation was performed using
anti-myc antibody and protein A. The co-immunoprecipitation com-
plex was washed extensively and run on a SDS^PAGE. The pro-
teins were transferred to membrane and blotted with anti-FLAG
antibody.
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residuals of hGBP3 were su⁄cient to bind to NIK/HGK,
whereas a deletion of the ¢rst 60 amino acids completely
eliminated the interaction between the two proteins. Thus
the N-terminal of hGBP3 is essential for mediating its inter-
action with NIK/HGK.
4. Discussion
GBPs are synthesized upon interferon activation [16,17] and
can be accumulated to high levels in interferon-treated cells,
thus qualify as potential intracellular mediators of the inter-
feron-induced antiviral and antiproliferation e¡ect. However,
the mechanism leading to the e¡ect was unknown [25]. Our
discovery that hGBP3 directly interacts with NIK/HGK sug-
gested a possible involvement of JNK signal transduction in
interferon-induced antivirus processes.
JNK, also known as stress-activated MAP kinase (SAPK),
plays crucial roles in stress response, cell proliferation, apo-
ptosis and ontogenesis. JNK kinase activity can be activated
by treatment of cells by cytokines (e.g. TNF and IL-1) and by
exposure of cells to various environmental stresses including
osmotic stress, redox stress, and radiation [28]. Previous
studies have demonstrated that double strand RNA and en-
cephalomyocarditis infection can activate JNK [31,33], and
overexpression of human GBP proteins blocks encephalomyo-
carditis replication in HeLa cells [25]. These reports were
consistent with our ¢ndings that hGBP3 could regulate the
phosphorylation of JNK through direct interaction with NIK/
HGK, and might possibly provide a link between the JNK
signaling and the antiviral e¡ect of interferons.
The C-terminal regulatory domain of NIK/HGK is com-
posed of a CHN domain, two PEST motifs and two polypro-
line consensus-binding sites for proteins containing Src ho-
mology (SH3) domains [4]. Nck binds to the SH3-binding
motif of NIK/HGK and activates the latter [28]. The C-ter-
minal of NIK/HGK also binds MEKK1; the latter is subse-
quently phosphorylated, and leads to JNK activation [28].
Our observation suggested that the CHN domain of NIK/
HGK bound to hGBP3 and thus assigns a new biological
function to the important region of the MAP4K.
Mammals have two protein kinase families related to Sac-
charomyces cerevisiae STE20 kinase; both activate JNK. One
is the PAK kinase family, which has an N-terminal regulatory
domain and a C-terminal kinase domain. The N-terminal of
PAKs contains a CDC42/Rac interaction and binding (CRIB)
domain [4], or PAKs are activated by GTP-bound Cdc42 and
Rac [4]. The other family is the GCK family including GCKs
and MST1, containing an N-terminal kinase domain and a
C-terminal regulatory region, and lacking a Cdc42- and Rac-
binding domain [4,19]. Our studies showed that although not
regulated by small GTP-binding proteins Cdc42 and Rac, the
GCK family member NIK/HGK could interact with another
GTP-binding protein, hGBP3. Since GBP proteins might also
bind GDP [18], it will be very interesting to ¢nd if the hGBP3
regulation of NIK/HGK is also a¡ected by the kind of cofac-
tors it binds, i.e. GTP or GDP. Further, it will be extremely
interesting to investigate the possible involvement of hGBP1
and hGBP2 in the regulation of NIK/HGK, and even other
group I GCKs including GLK, GCK, GCKR, and HPK1.
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